Market Overview

Trade GMED stock with recommended broker Ally Invest. Commissions as low as $3.95.

Analyst Rating View All Ratings

DateResearch FirmActionCurrentTarget
6/01/18Cantor FitzgeraldInitiates Coverage OnOverweight65.0
5/30/18Leerink SwannMaintainsOutperformOutperform61.0
5/03/18Morgan StanleyMaintainsOverweightOverweight58.0
Show more Loading articles...

Earnings View Earnings

Q1 2018 EST Actual Surprise
EPS: 0.36 0.41 0.05
Rev: 167.95M 174.41M 6.46M
Q2 2018 EST Actual Surprise
EPS: Expected
2018-08-01
Rev:

Company Profile